Events Calendar

OBN BioTuesday: 'Spotlight on Neurodegenerative Diseases'

Event Start Date: Tuesday, March 20, 2018 5:30 PM

Event End Date: Tuesday, March 20, 2018 9:30 PM

Event Locations

We are pleased to announce details of a special edition BioTuesday event that we are holding at the Babraham Institute in Cambridge which will provide a 'Spotlight on: Neurodegenerative Diseases'. 


Neurodegenerative diseases are incurable conditions in which nerve cells gradually degenerate, or die, for reasons that are not yet understood. Neurodegenerative diseases include Alzheimer's, Parkinson's, Huntington's, Motor Neurone disease, Creutzfeldt-Jakob and Multiple Sclerosis, many of which give rise to dementia.


Around 850,000 people in the UK have dementia with the number of people affected projected to reach 2 million by 2051. There is currently no cure for any of the neurodegenerative conditions that give rise to dementia, which represents one of the toughest medical and economic challenges facing our society today.


During the event, a line-up of expert speakers will provide a comprehensive and fascinating update on the latest research results and treatments available for neurodegenerative disease, including dementia, along with a review of government funding, a private investment industry update, and news from one of five  of the UK's 'Dementia Research Institutes' Centre's of Excellence.


We will also hear case studies from four of the most innovative companies in the UK who are working in the neurodegenerative space.




Registration and networking


Welcome and introductions


John Harris - CEO of OBN


Tony Jones - CEO of One Nucleus




Dr Geoff Butcher - Assistant Director of the Babraham Institute - will provide an update on their 'Healthy Ageing' themed research


Dr David Brown - will share an update on his research on 'Practical Lifestyles for Healthy Ageing and Reduced Neurodegeneration'


Tetsuyuki Maruyama - CSO at The Dementia Discovery Fund - will share an update on the DDF's collaboration between charity, industry and the government to provide investment in innovation for dementia research


Dr Joanna Wolak - Principal Research Scientist at Eli Lilly - will provide an update on Lilly's work in the neurodegenerative disease space 


Company showcase presentations


Jenny Barnett - CSO at Cambridge Cognition


Su Metcalf - Founder and CSO at LIFNano Therapeutics


Ciara Finucane - Imanova


Panel discussion and Q&A


Networking over drinks and nibbles


Evening close



The Petersfield Lecture Theatre, Babraham Research Campus, Cambridge, CB22 3AT



OBN & One Nucleus Members - First ticket complimentary, additional ticket - £25+VAT

Non Members - £50+VAT

Delegates will fit into one of the above price categories. Check your membership here.
izmir sınırsız escort Betboo
konak escort alsancak escort side escort antalya grup escort antalya grup escort ankara rus escort
antalya sınırsız escort sakarya sınırsız escort
konya genç escort
kaçak bahis siteleri restbet Betmatik Betmatik bonus veren siteler